COLLEGEVILLE, Pa., Feb. 22 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE - News), announced today the appointment of Geno Germano, 46, to President - U.S. and General Manager, Wyeth Pharmaceuticals. In this new role, Mr. Germano will continue to report to Mr. Joseph Mahady, newly appointed President - Global Business, Wyeth Pharmaceuticals and Senior Vice President, Wyeth.
Mr. Germano joined Wyeth in 1984 as a sales representative and has held positions of increasing responsibility in Sales, Marketing, Business Development and General Management, including Managing Director, Wyeth Australia and New Zealand; Executive Vice President and General Manager for Wyeth Global Vaccines; and most recently, Executive Vice President, Pharmaceutical Business Unit.
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
Source: Wyeth Pharmaceuticals
